cagrilintide semaglutide dosage and together drive record weight loss in global trial CagriSema Dosage Protocol: Research Reference

Prime/MRx is committed to using our real-world research to help our clients make informed benefit decisions for GLP-1 coverage as they navigate this dynamic landscape. For additional information and study design details, please refer to the year-two abstract

In research participants with MASLD, retatrutide demonstrated an 82.4% reduction in liver fat content, suggesting significant hepatic metabolic activity beyond its weight loss effects [4]

Phase II data showed 24.2% body weight reduction at 48 weeks

In: Robertson RP, editor

(We can access food and other dopamine-producing things at the press of a button.) Still, our brains are wired to be preoccupied with finding food and, when we do, to find it rewarding

Its primarily used to manage high blood sugar levels in people with type 2 diabetes, but its appetite-suppressing and metabolic-boosting properties have made it a sought-after treatment for weight loss